Tafinlar Prices, Coupons, Copay Cards & Patient Assistance
Tafinlar (dabrafenib) is a member of the multikinase inhibitors drug class and is commonly used for Low-Grade Glioma, Melanoma - Metastatic, Non Small Cell Lung Cancer, and others.
Tafinlar is available as a brand name drug only, a generic version is not yet available. View generic Tafinlar availability for more details.
Tafinlar prices
Oral Capsule
50 mg Tafinlar oral capsule from $11,932.36 for 120 capsules
| Quantity | Per unit | Price |
|---|---|---|
| 120 | $99.44 | $11,932.36 |
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
75 mg Tafinlar oral capsule from $15,375.55 for 120 capsules
| Quantity | Per unit | Price |
|---|---|---|
| 120 | $128.13 | $15,375.55 |
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
Oral Tablet, Soluble
10 mg Tafinlar oral tablet, soluble from $4,181.61 for 210 tablets
| Quantity | Per unit | Price |
|---|---|---|
| 210 | $19.91 | $4,181.61 |
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
Get your FREE Drugs.com Discount Card
Save up to 80% off the cost of prescription drugs and OTC medicines valid at over 65,000 pharmacies.
This is a drug discount program, not an insurance plan.
Tafinlar Coupons, Copay Cards and Rebates
Tafinlar offers may take the form of printable coupons, rebates, savings or copay cards, trial offers, or free samples. Certain offers may be printable from a website while others may require registration, completing a questionnaire, or obtaining a sample from a medical professional.
Tafinlar Novartis Oncology Universal Co-Pay Card
Eligible commercially insured patients may pay $25 per prescription with a maximum savings of $15,000 per calendar year.
- Applies to:
- Tafinlar
- Number of uses:
- per prescription per calendar year
Form more information phone: 877-577-7756 or Visit website
Patient Assistance & Copay Programs for Tafinlar
Patient assistance programs (PAPs) are typically sponsored by pharmaceutical companies and offer cost-free or discounted medicines, as well as copay programs, to individuals with low income or those who are uninsured/under-insured and meet specific criteria. Eligibility requirements for each program may vary.
Provider: Novartis Patient Assistance Foundation, Inc. (NPAF)
Eligibility requirements:- Contact program for details.
- Based on FPL
- Not specified
- Must be residing in the US or US territory
- Fabhalta: To start the application process apply to support.Fabhalta.com or (833) 993-2242. Kesimpta: To start the application process apply to Alongside™ Kesimpta at www.Kesimpta.com or (855) 537-4678. Kisqali: To start the application process apply to support.Kisqali.com or (866) 433-8000. Leqvio: To start the application process apply to Leqvio Service Center at www.Leqvio.com or (833) 537-8462. Lutathera: To start the application process call (844) 638-7222. Pluvicto: To start the application process call (844) 638-7222. Scemblix: To start the application process apply to support.Scemblix.com or (866) 433-8000. All medication will be shipped directly to the patient, unless otherwise noted. Please contact the program for a complete product listing. www.pap.novartis.com
- Tafinlar (dabrafenib) Capsule
More information please phone: 800-277-2254 Visit website
Provider: Patient Access Network Foundation (PAN)
Eligibility requirements:- *See Additional Information section below
- Between 400-500% of FPL
- FDA Approved Diagnosis - See Program Website for Details
- Must reside and receive treatment in US
- *Patients must have health insurance and their insurance must cover the qualifying medication for which they seek assistance. Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly. Note: All new enrollment is now done electronically or over the phone. Contact program for details.
- Tafinlar (dabrafenib) Capsule
More information please phone: 866-316-7263 Visit website
Disclaimer: Medication pricing is sourced from a variety of providers. Pricing may vary significantly due to several factors including brand or generic status, insurance coverage, pharmacy choice, location, and manufacturer pricing policies. Prices are subject to change. For the most accurate and up-to-date information, always consult directly with your pharmacy or healthcare provider.
See also:
More about Tafinlar (dabrafenib)
- Check interactions
- Compare alternatives
- Reviews (2)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: multikinase inhibitors
- Breastfeeding
- En español